Exact Mass: 717.6059624
Exact Mass Matches: 717.6059624
Found 480 metabolites which its exact mass value is equals to given mass value 717.6059624
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
PC(P-16:0/16:0)
C40H80NO7P (717.5672099999999)
PC(P-16:0/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/16:0), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of palmitic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-16:0/16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-16:0/16:0), in particular, consists of one chain of plasmalogen 16:0 at the C-1 position and one chain of palmitic acid at the C-2 position. The plasmalogen 16:0 moiety is derived from animal fats, liver and kidney, while the palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(14:0/P-18:0)
C40H80NO7P (717.5672099999999)
PC(14:0/P-18:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(14:0/P-18:0), in particular, consists of one chain of myristic acid at the C-1 position and one chain of plasmalogen 18:0 at the C-2 position. The myristic acid moiety is derived from nutmeg and butter, while the plasmalogen 18:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.
PC(16:0/P-16:0)
C40H80NO7P (717.5672099999999)
PC(16:0/P-16:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(16:0/P-16:0), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of plasmalogen 16:0 at the C-2 position. The palmitic acid moiety is derived from fish oils, milk fats, vegetable oils and animal fats, while the plasmalogen 16:0 moiety is derived from animal fats, liver and kidney. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids.
PC(P-18:0/14:0)
C40H80NO7P (717.5672099999999)
PC(P-18:0/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/14:0), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of myristic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. PC(P-18:0/14:0) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(P-18:0/14:0), in particular, consists of one chain of plasmalogen 18:0 at the C-1 position and one chain of myristic acid at the C-2 position. The plasmalogen 18:0 moiety is derived from animal fats, liver and kidney, while the myristic acid moiety is derived from nutmeg and butter. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
PC(O-16:0/16:1(9Z))
C40H80NO7P (717.5672099999999)
PC(O-16:0/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(O-16:0/16:1(9Z)), in particular, consists of one chain of Palmityl alcohol at the C-1 position and one chain of palmitoleic acid at the C-2 position. The Palmityl alcohol moiety is derived from animal fats and vegetable oils, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PCs can be synthesized via three different routes. In one route, choline is activated first by phosphorylation and then by coupling to CDP prior to attachment to phosphatidic acid. PCs can also synthesized by the addition of choline to CDP-activated 1,2-diacylglycerol. A third route to PC synthesis involves the conversion of either PS or PE to PC. PC(o-16:0/16:1(9Z)) is a phosphatidylcholine (PC or GPCho). It is a glycerophospholipid in which a phosphorylcholine moiety occupies a glycerol substitution site. As is the case with diacylglycerols, glycerophosphocholines can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PC(o-16:0/16:1(9Z)), in particular, consists of one chain of Palmityl alcohol at the C-1 position and one chain of palmitoleic acid at the C-2 position. The Palmityl alcohol moiety is derived from animal fats and vegetable oils, while the palmitoleic acid moiety is derived from animal fats and vegetable oils. Phospholipids, are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling.
DCHA-HF cpd
Phosphatidylcholine alkenyl 16:0-16:0
C40H80NO7P (717.5672099999999)
PC(O-14:0/18:1)
C40H80NO7P (717.5672099999999)
Lecithin
C40H80NO7P (717.5672099999999)
PC(O-16:0/16:1(9Z))
C40H80NO7P (717.5672099999999)
PC(O-18:0/14:1(9Z))
C40H80NO7P (717.5672099999999)
PC(P-20:0/12:0)
C40H80NO7P (717.5672099999999)
PE(O-16:0/19:1(9Z))
C40H80NO7P (717.5672099999999)
PE(O-18:0/17:1(9Z))
C40H80NO7P (717.5672099999999)
PE(O-20:0/15:1(9Z))
C40H80NO7P (717.5672099999999)
PE(P-16:0/19:0)
C40H80NO7P (717.5672099999999)
PE(P-18:0/17:0)
C40H80NO7P (717.5672099999999)
PE(P-20:0/15:0)
C40H80NO7P (717.5672099999999)
PC O-32:1
C40H80NO7P (717.5672099999999)
PE O-35:1
C40H80NO7P (717.5672099999999)
1-tetradecyl-2-[(9Z)-octadecenoyl]-sn-glycero-3-phosphocholine
C40H80NO7P (717.5672099999999)
A phosphatidylcholine O-32:1 in which the alkyl and acyl groups specified at positions 1 and 2 are tetradecyl and (9Z)-octadecenoyl respectively.
2-[[(E,2S,3R)-2-(heptadecanoylamino)-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E,2S,3R)-2-(hexadecanoylamino)-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(octadecanoylamino)heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
N-[(2s,3s,4r)-1-(Alpha-D-Galactopyranosyloxy)-3,4-Dihydroxyoctadecan-2-Yl]hexadecanamide
N-heptadecanoyl-1-O-beta-D-glucosyl-4-hydroxy-15-methylhexadecasphinganine
2-[hydroxy-[(E,2S,3R)-3-hydroxy-15-methyl-2-(octadecanoylamino)hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(2S,3R)-2-(heptadecanoylamino)-3-hydroxyoctadec-5-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
(13Z,16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-(1,3-dihydroxyoctan-2-yl)tetraconta-13,16,19,22,25,28,31,34,37-nonaenamide
(16Z,19Z,22Z,25Z,28Z,31Z,34Z,37Z)-N-[(E)-1,3-dihydroxyoct-4-en-2-yl]tetraconta-16,19,22,25,28,31,34,37-octaenamide
[3-octoxy-2-[(Z)-tetracos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
(9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E)-1,3-dihydroxyoctadeca-4,8-dien-2-yl]triaconta-9,12,15,18,21,24,27-heptaenamide
(14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexadeca-4,8,12-trien-2-yl]dotriaconta-14,17,20,23,26,29-hexaenamide
(11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(4E,8E)-1,3-dihydroxyhexadeca-4,8-dien-2-yl]dotriaconta-11,14,17,20,23,26,29-heptaenamide
(11Z,14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-(1,3-dihydroxydecan-2-yl)octatriaconta-11,14,17,20,23,26,29,32,35-nonaenamide
(6Z,9Z,12Z,15Z,18Z,21Z,24Z,27Z)-N-[(E)-1,3-dihydroxyoctadec-4-en-2-yl]triaconta-6,9,12,15,18,21,24,27-octaenamide
(13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E)-1,3-dihydroxytetradeca-4,8-dien-2-yl]tetratriaconta-13,16,19,22,25,28,31-heptaenamide
(10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]tetratriaconta-10,13,16,19,22,25,28,31-octaenamide
(8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]dotriaconta-8,11,14,17,20,23,26,29-octaenamide
(8Z,11Z,14Z,17Z,20Z,23Z)-N-[(4E,8E,12E)-1,3-dihydroxydocosa-4,8,12-trien-2-yl]hexacosa-8,11,14,17,20,23-hexaenamide
(10Z,13Z,16Z,19Z,22Z,25Z)-N-[(4E,8E,12E)-1,3-dihydroxyicosa-4,8,12-trien-2-yl]octacosa-10,13,16,19,22,25-hexaenamide
(7Z,10Z,13Z,16Z,19Z,22Z,25Z)-N-[(4E,8E)-1,3-dihydroxyicosa-4,8-dien-2-yl]octacosa-7,10,13,16,19,22,25-heptaenamide
(16Z,19Z,22Z,25Z,28Z,31Z)-N-[(4E,8E,12E)-1,3-dihydroxytetradeca-4,8,12-trien-2-yl]tetratriaconta-16,19,22,25,28,31-hexaenamide
(12Z,15Z,18Z,21Z,24Z,27Z)-N-[(4E,8E,12E)-1,3-dihydroxyoctadeca-4,8,12-trien-2-yl]triaconta-12,15,18,21,24,27-hexaenamide
(9Z,12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-(1,3-dihydroxydodecan-2-yl)hexatriaconta-9,12,15,18,21,24,27,30,33-nonaenamide
(15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(4E,8E)-1,3-dihydroxydodeca-4,8-dien-2-yl]hexatriaconta-15,18,21,24,27,30,33-heptaenamide
(4Z,7Z,10Z,13Z,16Z,19Z)-N-[(4E,8E,12E)-1,3-dihydroxyhexacosa-4,8,12-trien-2-yl]docosa-4,7,10,13,16,19-hexaenamide
(5Z,8Z,11Z,14Z,17Z,20Z,23Z,26Z,29Z)-N-(1,3-dihydroxyhexadecan-2-yl)dotriaconta-5,8,11,14,17,20,23,26,29-nonaenamide
(5Z,8Z,11Z,14Z,17Z,20Z,23Z)-N-[(4E,8E)-1,3-dihydroxydocosa-4,8-dien-2-yl]hexacosa-5,8,11,14,17,20,23-heptaenamide
(12Z,15Z,18Z,21Z,24Z,27Z,30Z,33Z)-N-[(E)-1,3-dihydroxydodec-4-en-2-yl]hexatriaconta-12,15,18,21,24,27,30,33-octaenamide
(7Z,10Z,13Z,16Z,19Z,22Z,25Z,28Z,31Z)-N-(1,3-dihydroxytetradecan-2-yl)tetratriaconta-7,10,13,16,19,22,25,28,31-nonaenamide
(14Z,17Z,20Z,23Z,26Z,29Z,32Z,35Z)-N-[(E)-1,3-dihydroxydec-4-en-2-yl]octatriaconta-14,17,20,23,26,29,32,35-octaenamide
(6Z,9Z,12Z,15Z,18Z,21Z)-N-[(4E,8E,12E)-1,3-dihydroxytetracosa-4,8,12-trien-2-yl]tetracosa-6,9,12,15,18,21-hexaenamide
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octacos-17-enoxy]propan-2-yl] heptanoate
C40H80NO7P (717.5672099999999)
3-Hydroxy-2-(2-hydroxypentacosanoylamino)hexadecane-1-sulfonic acid
C41H83NO6S (717.5940777999999)
3-Hydroxy-2-(2-hydroxydocosanoylamino)nonadecane-1-sulfonic acid
C41H83NO6S (717.5940777999999)
3-Hydroxy-2-(2-hydroxyicosanoylamino)henicosane-1-sulfonic acid
C41H83NO6S (717.5940777999999)
3-Hydroxy-2-(2-hydroxynonadecanoylamino)docosane-1-sulfonic acid
C41H83NO6S (717.5940777999999)
3-Hydroxy-2-(2-hydroxytetracosanoylamino)heptadecane-1-sulfonic acid
C41H83NO6S (717.5940777999999)
3-Hydroxy-2-(2-hydroxyhenicosanoylamino)icosane-1-sulfonic acid
C41H83NO6S (717.5940777999999)
3-Hydroxy-2-(2-hydroxyhexadecanoylamino)pentacosane-1-sulfonic acid
C41H83NO6S (717.5940777999999)
3-Hydroxy-2-(2-hydroxyheptadecanoylamino)tetracosane-1-sulfonic acid
C41H83NO6S (717.5940777999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonoxypropan-2-yl] (Z)-hexacos-15-enoate
C40H80NO7P (717.5672099999999)
3-Hydroxy-2-(2-hydroxyhexacosanoylamino)pentadecane-1-sulfonic acid
C41H83NO6S (717.5940777999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexacos-15-enoxy]propan-2-yl] nonanoate
C40H80NO7P (717.5672099999999)
3-Hydroxy-2-(2-hydroxypentadecanoylamino)hexacosane-1-sulfonic acid
C41H83NO6S (717.5940777999999)
3-Hydroxy-2-(2-hydroxyoctadecanoylamino)tricosane-1-sulfonic acid
C41H83NO6S (717.5940777999999)
3-Hydroxy-2-(2-hydroxytricosanoylamino)octadecane-1-sulfonic acid
C41H83NO6S (717.5940777999999)
[2-butanoyloxy-3-[(Z)-octacos-17-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[2-octanoyloxy-3-[(Z)-tetracos-13-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[3-[(Z)-hexacos-15-enoxy]-2-hexanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-heptadec-9-enoxy]propan-2-yl] octadecanoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-henicos-11-enoxy]propan-2-yl] tetradecanoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-icosoxypropan-2-yl] (Z)-pentadec-9-enoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-henicosoxypropan-2-yl] (Z)-tetradec-9-enoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-pentadecoxypropan-2-yl] (Z)-icos-11-enoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] docosanoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetracos-13-enoxy]propan-2-yl] undecanoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-nonadec-9-enoxy]propan-2-yl] hexadecanoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-pentadec-9-enoxy]propan-2-yl] icosanoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tridecoxypropan-2-yl] (Z)-docos-13-enoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-undecoxypropan-2-yl] (Z)-tetracos-13-enoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-docosoxypropan-2-yl] (Z)-tridec-9-enoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-heptadecoxypropan-2-yl] (Z)-octadec-9-enoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-nonadecoxypropan-2-yl] (Z)-hexadec-9-enoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-icos-11-enoxy]propan-2-yl] pentadecanoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-docos-13-enoxy]propan-2-yl] tridecanoate
C40H80NO7P (717.5672099999999)
[2-[(Z)-heptadec-9-enoyl]oxy-3-pentadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[3-[(Z)-nonadec-9-enoxy]-2-tridecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[2-dodecanoyloxy-3-[(Z)-icos-11-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[3-dodecoxy-2-[(Z)-icos-11-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[3-[(Z)-heptadec-9-enoxy]-2-pentadecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[2-[(Z)-nonadec-9-enoyl]oxy-3-tridecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[2-[(Z)-henicos-11-enoyl]oxy-3-undecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[2-decanoyloxy-3-[(Z)-docos-13-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[3-decoxy-2-[(Z)-docos-13-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[3-heptadecoxy-2-[(Z)-pentadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[2-heptadecanoyloxy-3-[(Z)-pentadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[3-[(Z)-henicos-11-enoxy]-2-undecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[2-nonadecanoyloxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[3-nonadecoxy-2-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[2-hexadecanoyloxy-3-[(E)-hexadec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
2-[[(E)-2-(heptadecanoylamino)-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
N-(hexacosanoyl)-pentadecasphinganine-1-phosphate
C41H84NO6P (717.6035933999999)
N-(docosanoyl)-nonadecasphinganine-1-phosphate
C41H84NO6P (717.6035933999999)
N-(tetracosanoyl)-heptadecasphinganine-1-phosphate
C41H84NO6P (717.6035933999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] henicosanoate
C40H80NO7P (717.5672099999999)
[2-hexadecanoyloxy-3-[(Z)-hexadec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-hexadec-9-enoxy]propan-2-yl] nonadecanoate
C40H80NO7P (717.5672099999999)
[2-octadecanoyloxy-3-[(Z)-tetradec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hexadecoxypropan-2-yl] (Z)-nonadec-9-enoate
C40H80NO7P (717.5672099999999)
[2-[(Z)-hexadec-9-enoyl]oxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-tetradecoxypropan-2-yl] (Z)-henicos-11-enoate
C40H80NO7P (717.5672099999999)
[3-octadecoxy-2-[(Z)-tetradec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[2-[(Z)-octadec-9-enoyl]oxy-3-tetradecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[3-[(Z)-octadec-9-enoxy]-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-octadec-9-enoxy]propan-2-yl] heptadecanoate
C40H80NO7P (717.5672099999999)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-octadecoxypropan-2-yl] (Z)-heptadec-9-enoate
C40H80NO7P (717.5672099999999)
2-[[(E,2R,3S)-2-(heptadecanoylamino)-3-hydroxyoctadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E,2S,3R)-2-(henicosanoylamino)-3-hydroxytetradec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(2S,3R)-2-[[(E)-heptadec-9-enoyl]amino]-3-hydroxyoctadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(nonadecanoylamino)hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(2S,3R)-2-[[(E)-hexadec-9-enoyl]amino]-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-octadec-1-enoxy]propan-2-yl] heptadecanoate
C40H80NO7P (717.5672099999999)
2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(E)-icos-11-enoyl]amino]pentadecoxy]phosphoryl]oxyethyl-trimethylazanium
[(2R)-3-[(E)-octadec-1-enoxy]-2-tetradecanoyloxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(octadecanoylamino)heptadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2R,3S)-3-hydroxy-2-(tridecanoylamino)docos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E,2S,3R)-2-(heptadecanoylamino)-3-hydroxyoctadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(icosanoylamino)pentadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
[(2S)-2-dodecanoyloxy-3-[(E)-icos-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
2-[hydroxy-[(2S,3R)-3-hydroxy-2-[[(E)-octadec-9-enoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(nonadecanoylamino)hexadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium
[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-hexadec-1-enoxy]propan-2-yl] nonadecanoate
C40H80NO7P (717.5672099999999)
2-[[(E,2S,3R)-2-(hexadecanoylamino)-3-hydroxynonadec-8-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(tetradecanoylamino)henicos-8-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(pentadecanoylamino)icos-8-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E,2S,3R)-2-(henicosanoylamino)-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
[(2R)-2-hexadecanoyloxy-3-[(E)-hexadec-1-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C40H80NO7P (717.5672099999999)
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(tetradecanoylamino)henicos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(icosanoylamino)pentadec-8-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2R,3S)-3-hydroxy-2-(tridecanoylamino)docos-8-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E,2S,3R)-3-hydroxy-2-(pentadecanoylamino)icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
[(2S)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(E)-icos-1-enoxy]propan-2-yl] pentadecanoate
C40H80NO7P (717.5672099999999)
2-[[(E)-2-(dodecanoylamino)-3-hydroxytricos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(nonadecanoylamino)hexadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(octadecanoylamino)heptadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-icos-11-enoyl]amino]pentadecoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(tridecanoylamino)docos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-dodec-5-enoyl]amino]-3-hydroxytricosoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(icosanoylamino)pentadec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-henicos-9-enoyl]amino]-3-hydroxytetradecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(hexadecanoylamino)-3-hydroxynonadec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]icosoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-tridec-8-enoyl]amino]docosoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(henicosanoylamino)-3-hydroxytetradec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(tetradecanoylamino)henicos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-nonadec-9-enoyl]amino]hexadecoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-octadec-11-enoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(pentadecanoylamino)icos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]henicosoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-hexadec-7-enoyl]amino]-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(propanoylamino)dotriacont-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(tricosanoylamino)dodec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(butanoylamino)-3-hydroxyhentriacont-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-heptadec-9-enoyl]amino]-3-hydroxyoctadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-hexadec-9-enoyl]amino]-3-hydroxynonadecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(tetracosanoylamino)undec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(octanoylamino)heptacos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-acetamido-3-hydroxytritriacont-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(hexanoylamino)-3-hydroxynonacos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(hexacosanoylamino)-3-hydroxynon-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-octadec-9-enoyl]amino]heptadecoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(docosanoylamino)-3-hydroxytridec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(heptacosanoylamino)-3-hydroxyoct-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(pentacosanoylamino)dec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-hexacos-15-enoyl]amino]-3-hydroxynonoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(decanoylamino)-3-hydroxypentacos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-docos-13-enoyl]amino]-3-hydroxytridecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[[(E)-2-(heptanoylamino)-3-hydroxyoctacos-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(nonanoylamino)hexacos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-tetracos-13-enoyl]amino]undecoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]docosoxy]phosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(pentanoylamino)triacont-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
2-[[2-[[(Z)-henicos-11-enoyl]amino]-3-hydroxytetradecoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
2-[hydroxy-[(E)-3-hydroxy-2-(undecanoylamino)tetracos-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
1-(1Z-hexadecenyl)-2-hexadecanoyl-glycero-3-phosphocholine
C40H80NO7P (717.5672099999999)
1-(1Z-octadecenyl)-2-tetradecanoyl-glycero-3-phosphocholine
C40H80NO7P (717.5672099999999)
1-myristoyl-2-(1-enyl-stearoyl)-sn-glycero-3-phosphocholine
C40H80NO7P (717.5672099999999)
1-palmitoyl-2-(1-enyl-palmitoyl)-sn-glycero-3-phosphocholine
C40H80NO7P (717.5672099999999)
1-O-(alpha-D-galactopyranosyl)-N-pamitoylphytosphingosine
A glycophytoceramide having an alpha-D-galactopyranosyl residue at the O-1 position and a palmitoyl (hexadecanoyl) group attached to the nitrogen.
phosphatidylcholine O-32:1
C40H80NO7P (717.5672099999999)
An alkyl,acyl-sn-glycero-3-phosphocholine in which the alkyl or acyl groups at positions 1 and 2 contain a total of 32 carbons and 1 double bond.
LPC(32:1)
C40H80NO7P (717.5672099999999)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
Hex1Cer(34:0)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
MePC(31:1)
C40H80NO7P (717.5672099999999)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved